NASDAQ:TBPH

Theravance Biopharma Stock Insider Trading

etoro logo Buy TBPH
*Your capital is at risk
$16.86
+0.0100 (+0.0593%)
At Close: Jul 31, 2026

Theravance Biopharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -71.89. In total, the insiders bought 582.81K and sold 861.64K TBPH shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-71.89
Buy 582.81K shares
Sell 861.64K shares
35% Buy Activity
Weak Negative Correlation
Buy Signal Low Confidence
Jun 12, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -71.89.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
May 20, 2025
Sell
Ordinary Shares
F-InKind
Winningham Rick E
Chief Executive Officer
CEO / President 15 364
Value: $145.2K
May 20, 2025
Sell
Ordinary Shares
F-InKind
Sawaf Aziz
SVP & Chief Financial Officer
C-Suite Officer 9 348
Value: $88.3K
May 20, 2025
Sell
Ordinary Shares
F-InKind
Grimaud Brett A.
SVP, Gen Counsel And Secretary
Officer 9 743
Value: $92.1K
May 20, 2025
Sell
Ordinary Shares
F-InKind
Farnum Rhonda
SVP, Comm & Medical Affairs
Officer 9 120
Value: $86.2K
May 20, 2025
Sell
Ordinary Shares
F-InKind
Farnum Rhonda
SVP, Comm & Medical Affairs
Officer 9 120
Value: $86.2K
May 20, 2025
Sell
Ordinary Shares
F-InKind
Grimaud Brett A.
SVP, Gen Counsel And Secretary
Officer 9 743
Value: $92.1K
May 20, 2025
Sell
Ordinary Shares
F-InKind
Sawaf Aziz
SVP & Chief Financial Officer
C-Suite Officer 9 348
Value: $88.3K
May 20, 2025
Sell
Ordinary Shares
F-InKind
Winningham Rick E
Chief Executive Officer
CEO / President 15 364
Value: $145.2K
May 20, 2025
Sell
Ordinary Shares
F-InKind
Miller Aine
SVP, Dev & Head Of Ire Office
Officer 9 701
Value: $91.7K
May 20, 2025
Sell
Ordinary Shares
F-InKind
Miller Aine
SVP, Dev & Head Of Ire Office
Officer 9 701
Value: $91.7K
May 19, 2025
Buy
Ordinary Shares
A-Award
Miller Aine
SVP, Dev & Head Of Ire Office
Officer 10 430
Value: $97.9K
May 19, 2025
Buy
Ordinary Shares
A-Award
Pakianathan Deepika
Director
Director 10 649
Value: $100.0K
May 19, 2025
Buy
Share Option (Right to Buy)
A-Award
Pakianathan Deepika
Director
Director 24 258
Value: $227.8K
May 19, 2025
Buy
Ordinary Shares
A-Award
O'connor Donal
Director
Director 10 649
Value: $100.0K
May 19, 2025
Buy
Share Option (Right to Buy)
A-Award
O'connor Donal
Director
Director 24 258
Value: $227.8K
May 19, 2025
Buy
Ordinary Shares
A-Award
Mitchell Dean J
Director
Director 10 649
Value: $100.0K
May 19, 2025
Buy
Ordinary Shares
A-Award
Grant Jeremy T
Director
Director 10 649
Value: $100.0K
May 19, 2025
Buy
Share Option (Right to Buy)
A-Award
Gray Susannah
Director
Director 24 258
Value: $227.8K
May 19, 2025
Buy
Ordinary Shares
A-Award
Gray Susannah
Director
Director 10 649
Value: $100.0K
May 19, 2025
Buy
Share Option (Right to Buy)
A-Award
Mitchell Dean J
Director
Director 24 258
Value: $227.8K
May 19, 2025
Buy
Ordinary Shares
A-Award
Mitchell Dean J
Director
Director 10 649
Value: $100.0K
May 19, 2025
Buy
Share Option (Right to Buy)
A-Award
O'connor Donal
Director
Director 24 258
Value: $227.8K
May 19, 2025
Buy
Ordinary Shares
A-Award
O'connor Donal
Director
Director 10 649
Value: $100.0K
May 19, 2025
Buy
Share Option (Right to Buy)
A-Award
Pakianathan Deepika
Director
Director 24 258
Value: $227.8K
May 19, 2025
Buy
Ordinary Shares
A-Award
Pakianathan Deepika
Director
Director 10 649
Value: $100.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT THERAVANCE BIOPHARMA
Theravance Biopharma
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also include Izencitinib, a gut-selective pan-janus kinase (JAK) inhibitor that is in Phase IIb/III clinical tr...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE